Pearl River Capital, LLC Corcept Therapeutics Inc Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $54,479 - $72,171	2,195 Added 9.64%	24,954 $810,000
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $500,015 - $769,254	22,759 New	22,759 $620,000
Q4 2022 Feb 13, 2023	SELL	$19.95 - $29.96 $46,044 - $69,147	-2,308 Reduced 15.13%	12,950 $263,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $13,609 - $16,045	-551 Reduced 3.49%	15,258 $391,000
Q2 2022 Aug 12, 2022	BUY	$17.33 - $25.3 $60,343 - $88,094	3,482 Added 28.25%	15,809 $376,000
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $203,765 - $310,763	12,327 New	12,327 $278,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.